Epidemiological models for breast cancer risk estimation

Ginekologia Polska

Volumn 82, Issue 6, 2011, Pages 451-454

  Lech, Rogulski ^a   Przemysław, Oszukowski ^b  

^a Instytut Centrum Zdrowia Matki Polki ^*  (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Breast cancer; Chemoprevention; Risk assessment; Statistical models

Indexed keywords

EID: 79960379256     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Data from Krajowa Baza Danych Nowotworowych: www.onkologia.org.pl/pl/p/7
2. Data from SEER (Surveillance Epidemiology and End Results): www.seer.cancer.gov
3. Data from NORDCAN: www-dep.iarc.fr/nordcan.htm
4. Rekomendacje Zarza{ogonek}du Głównego PTG w sprawie profilaktyki i wczesnej diagnostyki zmian w gruczole sutkowym. Gin Prakt. 2005, 84, 14-15.
5. Bińkowska M, De{ogonek}bski R. Screening mammography in Polish female population aged 45 to 54. Ginekol Pol. 2005, 76, 871-878.
6. Cuzick J, Baum M. Tamoxifen and contralateral breast cancer. Lancet. 1985, 2, 282.
7. Gail M, Brinton L, Byar D, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989, 1, 1879-1886.
8. Baker L. Breast cancer detection demonstration project: Five-year summary report. CA Cancer J Clin. 1982, 32, 194-225.
9. Costantino J, Gail M, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999, 91, 1541-1548.
10. Rockhill B, Spiegelman D, Byrne C, et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001, 93, 58-366.
11. Decarli A, Calza S, Masala G, et al. Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort. J Natl Cancer Inst. 2006, 98, 1686-1693.
12. Fisher B, Costantino J, Wickerham D, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998, 90, 1371-1388.
13. Cuzick J, Powles T, Veronesi U, et al. Overview of the main outcomes in breast cancer prevention trials. Lancet. 2003, 361, 296-300.
14. Claus E, Risch N, Thompson W. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet. 1991, 48, 232-242.
15. Amir E, Evans D, Shenton A, et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet. 2003, 40, 807-14.
16. McTiernan A, Kuniyuki A, Yasui Y, et al. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. Cancer Epidemiol Biomarkers Prev. 001, 10, 333-338.
17. Parmigiani G, Berry D, Aquilar O. Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Am J Hum Genet. 1998, 62, 145-148.
18. Antoniou A, Pharoah P, Smith P, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer. 2004, 91, 1580-1590.
19. McIntosh A, Shaw C, Evans G, et al. Clinical Guidelines and Evidence Review for The Classification and Care of Women at Risk of Familial Breast Cancer. London: National Collaborating Centre for Primary Care/University of Sheffield, 2004.
20. Tyrer J, Duffy S, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004, 23, 1111-1130.
21. Cuzick J, Forbes J, Sestak I, et al. Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial. J Natl Cancer Inst. 2007, 9, 272-282.
22. Gail M, Rimer B. Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol. 1998, 16, 3105-3114.
23. McPherson C, Nissen M. Evaluating a risk-based model for mammographic screening of women in their forties. Cancer. 2002, 94, 2830-2835.
24. Boyd N, Lockwood G, Byng J, et al. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7, 1133-1144.